Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grape Seed Extract and Glycyrrhizin for Revascularization of Necrotic Immature Teeth
NCT07236567Not yet recruiting
- Sponsor
- Al-Azhar University
- Start
- Dec 2025
- Primary completion
- Oct 2027
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised trial of grape seed extract and glycyrrhizin in pulp necrosis (3 arms), sponsored by Al-Azhar University. Primary endpoints: Digital count of E. faecalis at 1 week and Clinical evaluation success at 1 week. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
grape seed extractglycyrrhizin
03
Conditions
pulp necrosis
Beyond the preview
Go deeper on NCT07236567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07236567.